Literature DB >> 21644006

The International Core Literature Consensus (ICLC): an alternative curriculum for Oncologists.

Shilpen Patel1, Reshma Jagsi, Natalie Cook, Luke Hughes-Davies, Christine Parkinson.   

Abstract

Oncologists must familiarize themselves with a complex evidence base. Several curricula have been devised, but it is not clear how these are used. We chose breast cancer, since this has a large literature base. Of the 285 radiation and medical oncology trainees in the USA and UK responding to our survey, over 90% reported knowledge of the literature was essential. Just over half of respondents had actually read the ASCO or ESMO curricula, with only 23% reporting that the curricula were important in their learning. Our survey revealed dissatisfaction with current curricula and a demand for more pragmatic literature guidance. We designed an alternative curriculum by using a 21-member peer review group to validate a list of key papers in breast oncology. Oncologists in training need guidance to direct their study. A curriculum based on an International Core Literature Consensus might match the needs of trainees more closely.

Entities:  

Mesh:

Year:  2011        PMID: 21644006     DOI: 10.1007/s13187-011-0242-y

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  12 in total

Review 1.  The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.

Authors: 
Journal:  J Natl Cancer Inst Monogr       Date:  2001

2.  Recommendations for a Global Core Curriculum in Medical Oncology.

Authors:  H H Hansen; D F Bajorin; H B Muss; G Purkalne; D Schrijvers; R Stahel
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

3.  ACCO: ASCO core curriculum outline.

Authors:  Hyman B Muss; Jamie Von Roenn; Lloyd Earl Damon; Lisa Marie Deangelis; Lawrence E Flaherty; Paul M Harari; Karen Kelly; Michael P Kosty; Matthew J Loscalzo; Robert Mennel; Beverly S Mitchell; Joanne E Mortimer; Franco Muggia; Edith A Perez; Peter W T Pisters; Leonard Saltz; Lidia Schapira; Joseph Sparano
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

4.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

Authors:  B Fisher; J Dignam; N Wolmark; E Mamounas; J Costantino; W Poller; E R Fisher; D L Wickerham; M Deutsch; R Margolese; N Dimitrov; M Kavanah
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

5.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

6.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

7.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

8.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Authors:  Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Peter E Besnard; Harmine M Zonderland; Inge Marie Obdeijn; Radu A Manoliu; Theo Kok; Hans Peterse; Madeleine M A Tilanus-Linthorst; Sara H Muller; Sybren Meijer; Jan C Oosterwijk; Louk V A M Beex; Rob A E M Tollenaar; Harry J de Koning; Emiel J T Rutgers; Jan G M Klijn
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

9.  Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Authors:  I Craig Henderson; Donald A Berry; George D Demetri; Constance T Cirrincione; Lori J Goldstein; Silvana Martino; James N Ingle; M Robert Cooper; Daniel F Hayes; Katherine H Tkaczuk; Gini Fleming; James F Holland; David B Duggan; John T Carpenter; Emil Frei; Richard L Schilsky; William C Wood; Hyman B Muss; Larry Norton
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

10.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

Authors:  Umberto Veronesi; Giovanni Paganelli; Giuseppe Viale; Alberto Luini; Stefano Zurrida; Viviana Galimberti; Mattia Intra; Paolo Veronesi; Chris Robertson; Patrick Maisonneuve; Giuseppe Renne; Concetta De Cicco; Francesca De Lucia; Roberto Gennari
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

View more
  2 in total

1.  The Impact of Massed and Spaced-Out Curriculum in Oncology Knowledge Acquisition.

Authors:  Dario Cecilio-Fernandes; Wytze S Aalders; Jakob de Vries; René A Tio
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

Review 2.  Motivations for and Challenges in the Development of Global Medical Curricula: A Scoping Review.

Authors:  Meredith Giuliani; Maria Athina Tina Martimianakis; Michaela Broadhurst; Janet Papadakos; Rouhi Fazelzad; Erik W Driessen; Janneke Frambach
Journal:  Acad Med       Date:  2021-03-01       Impact factor: 7.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.